HLB Therapeutics

115450 · KOSDAQ · Industrials · SMALL CAP

Early redemption of convertible bonds (incl. overseas CBs)

HLB Therapeutics acquired, prior to maturity on August 20, 2026, the full US$4.22M face amount of its 17th-round privately placed convertible bonds for US$4.29M (principal plus interest), offsetting the amount against third-party-allotted capital increase proceeds, so as to retire the bonds through a debt-for-equity conversion.

Capital raise(Early redemption of convertible bonds (incl. overseas CBs))· FILED 2026-08-06· RCEPT 20260806900681

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-08-21) →

What happened

HLB Therapeutics / Pre-maturity acquisition of convertible bonds (including overseas convertible bonds) after issuance / (2026.08.06) Pre-maturity acquisition of convertible bonds (including overseas convertible bonds) after issuance

Pre-maturity acquisition of convertible bonds (including overseas convertible bonds) after issuance Convertible bonds (overseas convertible bonds), Round 17

1. Matters concerning the bonds acquired before maturity Type of bonds: Unregistered, unsecured, privately placed convertible bonds Issuance date: 2024-11-21 Issuance method: Domestic issuance (private placement) Conversion price per share (KRW): 6,090 Maturity date: 2027-11-21

2. Bond acquisition amount (currency unit): 6,106,299,000 KRW (South Korean Won) - Face (electronically registered) total amount of bonds acquired (currency unit): 6,000,000,000 KRW (South Korean Won) - Base exchange rate: - - Acquisition date: 2026-08-20

3. Face (electronically registered) total amount of the bonds after acquisition (currency unit): 0 KRW (South Korean Won)

4. Reason for pre-maturity acquisition and future handling method: Offset of debt through debt-for-equity conversion and cancellation of the bond certificates

5. Source of acquisition funds: Offset against paid-in funds from a third-party-allotted capital increase

6. Method of bond acquisition: Over-the-counter purchase

7. Other matters for reference in investment decisions - The above "2. Bond acquisition amount" includes both principal and interest. - The above "2. Acquisition date" is the date the bond acquisition amount was offset. - The above conversion price per share is the conversion price as adjusted due to a decline in the market price and the free share distributions on December 19, 2024, January 13, 2025, and March 13, 2026.

* Related disclosures 2024-11-15 Decision to issue convertible bonds (Round 17) 2024-12-19 Decision on free share distribution 2024-12-19 Setting of the register-closing period or record date 2025-01-13 Decision on free share distribution 2025-05-21 Adjustment of conversion price (Round 17) 2025-08-21 Adjustment of conversion price 2026-02-26 Decision on free share distribution 2026-02-26 Setting of the register-closing period or record date

Filed2026-08-06, Early redemption of convertible bonds (incl. overseas CBs)
SourceDART rcept 20260806900681 → open original filing

Versions of this filing

  1. 2026-08-06Original (this page)
  2. 2026-08-21Amendment 1

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-08-06 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).